The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT06503016
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose supportive care
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Università Vita-Salute San Raffaele
- Registry
-
NCT06503016
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT06503016. Randomized; double masking; primary purpose supportive care. Start 2024-10-08 (actual); primary completion 2026-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
- Acronym
- SPHERE
- Condition
- Hypotension
- Condition
- Consciousness, Level Altered
- Condition
- Airway Disease
- Condition
- Respiratory Failure
- Condition
- Tachypnea
- Condition
- Bradypnea
- Condition
- Tachycardia
- Condition
- Bradycardia
- Condition
- Cardiac Failure
- Condition
- Cardiac Arrest
- Intervention (Drug)
- Phosphocreatine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Università Vita-Salute San Raffaele
- Collaborator
- Silvia Ajello
Record details
- Record id
cardio:ct-nct06503016- Content hash
797b1940e34885518692b3cb5c8a7bd531faa02a6d1ab3a44a247242ddda877d